Whenever there is disagreement between the perceived direction the company is moving and the direction the company is trading, it is important to dive deeper into the company’s financial statements to find the cause. Sometimes, Mr. Market is overreacting to a news item (e.g. CEO resignation), in which case the value investor may decide now is a great time to buy. However, this isn’t always the case, and there is little success found in blindly being a contrarian.
SKX’s P/E is low, but it is low not just as a result of a declining numerator, but because of a historically and temporarily high denominator. SKX’s TTM earnings are 2.6x higher than their three year average, as a result of the introduction of their pioneering “toner” shoes, which have a rounded bottom that has led the company to make controversial health claims. These shoes are selling extremely well, but due to the effects of competition, sales are slowing as new entrants in this category have begun flooding the market with their own toners. This has led to a significant number of order cancellations in the last quarter, resulting in a build-up in inventory.
As a value investor, we know that the company’s long term track record is a more useful gauge for setting expectations about future performance than a short-term spike. If we use SKX’s three year average earnings, we see that the company is trading at a much more reasonable (for the industry) P/E of 16. Still slightly below their competitor’s range, but not providing a margin of safety.
On both a NAV and EPV analysis, SKX is accurately priced (or, ever so slightly overpriced). An investment in SKX would amount to a speculative bet on the company’s ability to confound expectations based on its historical track record and thwart its competitor’s efforts to enter the toner market. Currently, all evidence points to the contrary.
Talk to Frank about Skechers
Authors Disclosure: At publication, the author DOES NOT have a position in the securities of this company.